|1.||Park, Mi Hye: 1 article (01/2010)|
|2.||Lee, Mi Hee: 1 article (01/2010)|
|3.||Kim, Young Ju: 1 article (01/2010)|
|4.||Jung, Sung-Chul: 1 article (01/2010)|
|5.||Lee, Sang Mi: 1 article (01/2010)|
|6.||Jeon, Yeo Jin: 1 article (01/2010)|
|7.||Leung, Patrick: 1 article (05/2008)|
|8.||Wang, Vivien: 1 article (05/2008)|
|9.||Hart, John: 1 article (05/2008)|
|10.||Oertelt, Sabine S: 1 article (05/2008)|
|1.||Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
09/01/1991 - "Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study."
07/01/2006 - "Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis."
03/15/2000 - "Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display."
08/01/1999 - "Second, in primary biliary cirrhosis (PBC), the need for population screening to ascertain prevalence and detect preclinical cases can be met by a rapid automated procedure for detection, by specific enzyme inhibition in microtitre wells, of antibody (anti-M2) to the pyruvate dehydrogenase complex E2 subunit (PDC-E2). "
06/01/1993 - "Antibody to two forms of dihydrolipoamide acetyltransferase (PDC-E2) in primary biliary cirrhosis."
|2.||Liver Diseases (Liver Disease)
|3.||Schizophrenia (Dementia Praecox)
03/01/2004 - "Alterations of other proteins (dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex E2, guanine deaminase, alpha-enolase, aconitase, ATP-synthase and alpha-internexin), have not, to the best of our knowledge, earlier been implicated in schizophrenia pathology. "
05/01/2002 - "Anti-neutrophil cytoplamic antibody (ANCA), anti-dihydrolipoamide dehydrogenase (anti-E3), rheumatoid factor (RF), anti-dihydrolipoamide acetyltransferase (anti-E2), anti-SS-A/Ro (60 kD), anti-SS-A/Ro (52 kD), anti-SS-B/La, anti-topoisomerase II (anti-topo II), anti-cardiolipin (aCL), anti-dsDNA, anti-ssDNA, anti-nuclear antibodies (ANA), anti-proteinase 3 (anti-Pr3) and anti-myeloperoxidase (anti-MPO) were determined in sera from 516 patients with HCV infection, 11 with primary biliary cirrhosis (PBC) and 44 healthy controls. "
|2.||Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)
|5.||Dihydrolipoyllysine-Residue Acetyltransferase (Dihydrolipoyl Transacetylase)
|6.||Myeloblastin (Proteinase 3)
|7.||Antineutrophil Cytoplasmic Antibodies (ANCA)
|8.||Complementary DNA (cDNA)
|10.||Proteins (Proteins, Gene)